Trial intelligence / Profile preview

NSAID vs Steroid in Trabeculectomy Wound Management

NCT03751059Phase 4Unknown

Start
Nov 2020
Primary completion
Sep 2021
Modality
Small Molecules
01

Overview

Phase 4, randomised trial of bromfenac sodium in open-angle glaucoma (OAG) (2 arms). Primary endpoint: Target Intraocular Pressure at 12 months. Status: unknown.

02

Drugs

bromfenac sodium
03

Conditions

open-angle glaucoma (OAG)

Beyond the preview

Go deeper on NCT03751059.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03751059.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call